via Mercor
Disease-Area Clinician — Trial Endpoints & Prescribing
Remote — US-based or deep US-market experience · Part-time · $150-230/hr
Is Mercor legit? Read our evidence-based Mercor review.
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a disease-area clinician for a paid pilot, with the potential to continue as the work scales.
Responsibilities
- Create and critique rubrics that analyze commercial drugs and drug-development programs
- Interpret clinical trial endpoints and judge whether results would change prescribing
- Assess what that means for real-world uptake in your therapeutic area
- Apply this across the pilot's set of drugs and programs
Requirements
- US-based disease-area clinician (practising physician, MD/DO)
- Familiarity with biotech/pharma development programs
- Deep expertise in a specific therapeutic area
- Board-certified and actively practising in your specialty
Engagement Details
- Duration: Approximately 10–20 hours over a 1–2 week pilot
- Remote — US-based
Why Participate
- Help improve expert AI evaluation of drugs and drug-development programs
- Recurring engagement for strong contributors
Listing sourced from Mercor. Annotation Academy is independent of these platforms and does not guarantee work or pay. See our disclosures.